Pancreatic Cancer Clinical Trials

Showing 301-320 of 565 trials

DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer

NCT05604573

Based on the cell free nucleic acid analysis information of blood samples and genetic mutation profile of EUS-FNB tissue from pancreatic cancer, the concordance between them is evaluated. And based on this information, biomarkers for diagnosis, treatment, and prognosis of pancreatic cancer are explored.

Pancreatic Cancer

Seoul National University Hospital150 participantsStarted Feb 2022

Seoul, South Korea

ACTIVE_NOT_RECRUITINGNA

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

NCT03621644

High-dose magnetic resonance imaging (MRI) guided hypofractionated radiation therapy delivered using daily adaptive dose planning has been shown in a retrospective study to result in improved overall survival, relative to patients receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastrointestinal toxicity. The goal of the proposed trial is to investigative in a controlled, prospective manner the robustness of this outcome, and to track quality of life over a 5-year trial period.

Pancreatic Cancer

Viewray Inc.133 participantsStarted Jan 2019

Los Angeles, California, United States • Miami, Florida, United States • Miami, Florida, United States +10 more locations

DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

Related Searches

Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer

Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer

Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)

A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）

Predicting Disease Progression and/or Recurrence in Cancer

Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer

Is One Pass Enough for the Diagnosis of the Pancreatic Masses During EUS-FNB?

Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer

BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.

Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC)

Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer

Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial

Surgery for Liver Metastases From PDAC

Post-operative Drainage After Pancreaticoduodenectomy

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma